Humana (HUM) AGM 2026 summary
Event summary combining transcript, slides, and related documents.
AGM 2026 summary
22 Apr, 2026Opening remarks and agenda
Meeting opened by the Chairman, with thanks to stockholders and an overview of the meeting's electronic materials and rules of conduct.
Voting window opened for stockholders, with instructions for proxy and live voting.
Formal business included election of directors, auditor ratification, executive compensation advisory vote, stock incentive plan approval, and a shareholder proposal on golden parachutes.
Shareholder proposals
Proposal 5 requested shareholder approval for executive severance exceeding 2.99x salary plus bonus, citing long-term stock underperformance.
Proponent noted partial adoption of the proposal by the board and referenced similar support at other companies.
Overview of voting outcomes
All director nominees were elected.
Auditor ratification, executive compensation advisory vote, and the 2026 Stock Incentive Plan were approved.
The shareholder proposal on excessive golden parachutes was not approved.
Latest events from Humana
- Q2 2026 delivered strong growth, margin gains, and robust membership, with guidance reaffirmed.HUM
Q2 2026 - 1Q26 Adjusted EPS hit $10.31, revenue up 23.5%, with robust membership and margin gains.HUM
Q1 2026 - FY 2025 adjusted EPS hit $17.14; FY 2026 targets $9 EPS and 25% MA growth amid Stars headwind.HUM
Q4 2025 - Q3 Adjusted EPS $3.24, revenue up 11%, and FY 2025 EPS outlook reaffirmed at $17.00.HUM
Q3 2025 - 2025 Adjusted EPS and revenue guidance raised on strong segment growth and stable cash flows.HUM
Q2 2025 - Q3 beat expectations; 2024 EPS outlook raised; MA and CenterWell growth offset by margin pressure.HUM
Q3 2024 - Q2 2024 outperformed; Adjusted EPS guidance held at ~$16.00 amid strong MA growth and cost pressures.HUM
Q2 2024 - Q1 net income and EPS surged, 2025 guidance reaffirmed, CenterWell and Medicaid grew strongly.HUM
Q1 2025 - 2024 Adjusted EPS $16.21; 2025 guidance steady; major MA decline, Medicaid and CenterWell growth.HUM
Q4 2024